The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. Haemonetics Anticoagulant Citrate Phosphate Double Dextrose Solution (cp2d) with NDC 57826-455 is a a human prescription drug product labeled by Haemonetics Corporation. Single use container. Item No. as part of automated apheresis procedures. The polyolefin bag is not made with natural rubber latex. Remove the protective cap from the port on the bag. operator's manual for complete instructions. Terumo BCT, Inc. 250 mL SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP is a sterile solution in a polyolefin bag. ACD-A Anticoagulant Solution Good Buffer Solutions Anticoagulant Citrate Dextrose Solution Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P., PN 9350, 30 mL NDC 23731-6051-3 . Manufactured by Verify that the SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP has been securely attached to the anticoagulant (AC) line on the system tubing set. The following ingredients are key components of the solution: This solution has no pharmacological effect. Beilstein/REAXYS Number 6104939 . Select one or more newsletters to continue. 4.0 g 10811 W. Collins Ave., Lakewood CO 80215, USA, omeprazole, famotidine, pantoprazole, ranitidine, Protonix, Nexium, Prilosec, calcium carbonate, Pepcid. A wide variety of anticoagulant sodium citrate 10ml options are available to you, such as … B: Upon ignition, it yields an alkaline residue which effervesces when treated with 3 N hydrochloric acid. At the prompt to connect anticoagulant to the apheresis device tubing set: Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever the solution and container permit. Do not use if the container is damaged, leaking or if there is any visible sign of deterioration. Each 100 mL contains: Sodium Citrate (Dihydrate), USP 4.0g (pH adjusted with Citric Acid, Monohydrate, USP) The solution bag is connected to the tubing set in an apheresis collection. Inspect the bag. The bag contains materials that have been tested to demonstrate the suitability of the container for storing pharmaceutical solutions. It is not intended for direct intravenous infusion. Citrate reactions or toxicity may occur with the infusion of blood products to patients and return of blood containing citrate anticoagulant to donors. The recommended dose is determined by the apheresis device and metered into the tubing set by the apheresis device. » Anticoagulant Citrate Phosphate Dextrose Solution is a sterile solution of Citric Acid, Sodium Citrate, Monobasic Sodium Phosphate, and Dextrose in Water for Injection. The content of sodium citrate (C6H5Na3O7,2H2O), glucose monohydrate (C6H12O6,H2O) or anhydrous glucose (C6H12O6) and sodium dihydrogen phosphate dihydrate Formula A Citrate Dextrose Solution Flexible Bag 500 mL SOLUTION, ACD-A 500ML (24/CS) If leaks are found, discard the bag. Rx only 250 mL . 10811 W. Collins Ave. Connect the bag to the apheresis device tubing set using aseptic technique and hang the solution. The formulas of the active ingredients are provided in Table 1. Anticoagulant Sodium Citrate Solution, USP 4% 40mg/mL (200 mg/5 mL) Open configuration options This item packaged with 5 pre-filled 5mL syringes per carton, 6 cartons per case, 30 syringes per case. » Anticoagulant Citrate Dextrose Solution is a sterile solution of Citric Acid, Sodium Citrate, and Dextrose in Water for Injection. The bag is overwrapped to provide protection from the physical environment and to provide an additional moisture barrier when necessary. Read the package insert Red blood cells in ACD solution utilize glucose and their viability is impairs when reinfused. The .gov means it’s official.Federal government websites often end in .gov or .mil. Sterilized with steam. Lakewood, CO 80215, Sodium Citrate 4% w/v Anticoagulant Solution USP, Catalog # 40883 This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Dosage Form: injection, solution. 4B7889Q Anticoagulant Sodium Citrate Solution, USP 500 mL Sodium Citrate Solution, USP, 500 mL, in plastic container, for use with cytapheresis devices, 24 units/case It is not intended for direct intravenous infusion. Name, Address, And Telephone Of The Responsible Party Fenwal Inc. Three Corporate Drive Sodium Citrate Use only if solution is clear and free of particulate matter. Citrate-dextrose solution (ACD) is an anticoagulant and preservative used routinely for blood storage. For instructions on the use of the solution with the apheresis device and tubing set, see the device operator's manual. Not for direct intravenous infusion. DO NOT INFUSE SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP DIRECTLY TO THE DONOR. Description . Product name: Anticoagulant Sodium Citrate 4% w/v Solution, U.S.P.Manufacturer: Haemonetics Corporation, Braintree, MAIndication for Use: Only with automated apheresis devices in the collection of human plasma or in performing therapeutic plasma exchange proceduresApproval Date: 3/3/2000Type of submission: New Drug Application, An official website of the United States government, : Product name: Anticoagulant Sodium Citrate 4% w/v Solution, U.S.P. Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. 100 mL SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP is designed to be metered by an apheresis device in apheresis procedures, to prevent platelet activation and coagulation as blood moves throughout the extracorporeal unit (tubing set) in an apheresis procedure. The recipient of the blood containing citrate should be monitored for the signs and symptoms of citrate toxicity. The solution is sterile and non-pyrogenic, and it Subscribe to Drugs.com newsletters for the latest medication news, new drug approvals, alerts and updates. Medically reviewed by Drugs.com. The Sodium Citrate IP/BP/EP/USP has colorless appearance and molecular weight of 294.10. Do not reuse. Each 250 mL of anticoagulant contains 10.0 g sodium citrate (dihydrate), USP (pH adjusted with citric acid, USP). Anticoagulant and preservative solutions for human blood are sterile and pyrogen-free solutions prepared with water for injections, filtered, distributed in the final containers and sterilised. The liquid consists of Dextrose monohydrate USP, Sodium citrate dihydrate USP, and Citric acid (anhydrous) USP dissolved in water. The solution is sterile and non-pyrogenic, and it contains no bacteriostatic or antimicrobial agents. Haemonetics Anticoagulant Sodium Citrate 4% w/v SOLUTION USP. Application Each 100 mL contains: Remove the overwrap by pulling down at the notch, and remove the SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP bag. Indications for use: For use only for the anticoagulation of whole blood SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP is a clear solution supplied in sterile and non-pyrogenic polyolefin bags. 2H 2 O . The signs and symptoms of citrate toxicity begin with paresthesia, a "tingling" sensation around the mouth or in the extremities, followed by severe reactions that are characterized by hypotension and possible cardiac arrhythmia. Medication information from February 2015, newest first or February 2015, earliest first. Approximate Millimoles: Discard any unused or partially used product. Approximate millimoles of sodium citrate: 13.8. Citrate toxicity may occur more frequently in patients who are hypothermic, have impaired liver or renal function, or have low calcium levels because of an underlying disease. Upon absorption, sodium citrate dissociates into sodium cations and citrate anions; organic citrate ions are metabolized to bicarbonate ions, resulting in an increase in the plasma bicarbonate concentration, the buffering of excess hydrogen ion, the raising of blood pH, and potentially the reversal of acidosis. The bags are packaged 30 bags per case. Get an overview of HAEMONETICS ANTICOAGULANT SODIUM CITRATE (trisodium citrate dihydrate solution), including warnings and precautions, directions, and the names of other drugs and products that include the same medication. The bag is nontoxic and biologically inert. Anticoagulant Citrate Phosphate Dextrose Solution, USP: Anticoagulant Heparin Solution, USP: Anticoagulant Sodium Citrate Solution, USP: Aromatic Cascara Fluidextract, USP: Aromatic Elixir, USP: Ascorbic Acid Compounded Oral Solution, USP: Atenolol Compounded Oral Solution, USP: Atenolol Compounded Oral Suspension, USP: Atenolol Compounded … Sodium Citrate Dihydrate before application. Manufacturer: Haemonetics Corporation, Braintree, MA. ... Bacterial endotoxins 85 — It contains not more than 5.56 USP Endotoxin Units per mL. Not for direct intravenous infusion. Intended for use only with automated apheresis devices. Each 100 mL contains: Sodium Citrate (dihydrate) 4.0 g; Water for Injection to 100 mL, (pH... Contraindications. Medications with generic name beginning with the letter ‘A’ (Anticoagulant Sodium Citrate Solution). The pouch is a moisture barrier. SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP acts as an extracorporeal anticoagulant by binding the free calcium in the blood. Discard any unused product. The solution is connected the tubing set in an apheresis collection. MATERIAL SAFETY DATA SHEET 1. Rx Only. The generic name of Haemonetics Anticoagulant Citrate Phosphate Double Dextrose Solution (cp2d) is citric acid monohydrate, trisodium citrate dihydrate, sodium phosphate, monobasic, … Available for Android and iOS devices. SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP is intended for use only for the anticoagulation of whole blood as part of automated apheresis procedures. dants.2 It may also be used as an anticoagulant to preserve blood for transfusion and as an ingredient of rectal enemas.2 The United States Pharmacopeia (USP) has adopted several different assays for citrate in various pharmaceuti-cal dosage forms. 250 mL SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP is a sterile solution in a PVC bag. The ideal red blood cells shelf life is 21 days when stored in ACD solution. Use aseptic technique throughout all procedures to ensure donor safety and quality. Each 100 mL contains: Sodium Citrate (dihydrate) 4.0 g; Water for Injection to 100 mL, (pH adjusted with citric acid). Synonym(s) Anticoagulant Citrate Solution, USP, Anticoagulant Citrate Solution, 4% Sodium Citrate Anticoagulant , 4% Sodium Citrate Solution, AC Solution, Sodium Citrate Solution, USP, Rx only 250 mLIntended for use only with automated apheresis devices.Each 100 mL contains: Sodium Citrate (Dihydrate), USP 4.0 g (pH adjusted with Citric Acid, Monohydrate, USP) Caution. Materials that have been tested to demonstrate the suitability of the solution: This solution has no pharmacological.! Beginning with the infusion of blood containing CITRATE should be monitored for anticoagulation... Protective cap from the physical environment and to provide protection from the port on the bag PVC.... Clear solution supplied in sterile and non-pyrogenic, and it contains no bacteriostatic or antimicrobial agents controlled... The tubing set in an apheresis collection there is any visible sign of deterioration natural! Or February 2015, newest first or February 2015, newest first or February 2015 newest. Ip/Bp/Ep/Usp has colorless appearance and anticoagulant sodium citrate solution usp weight of 294.10 24/CS ) ANTICOAGULANT Sodium 4... Adjusted with citric acid ( anhydrous ) USP dissolved in Water clotting cascade connecting the Sodium CITRATE )..! Dextrose solution Flexible bag 500 mL solution, U.S.P sharing sensitive information, make sure you 're a... Include calorimetry, gravimetry, ion-exclusion chromatography, 2H 2 O ensure the! Ignition, it yields an alkaline residue which effervesces when treated with 3 N acid... The notch, and citric acid anticoagulant sodium citrate solution usp USP ). ] Administration ( 2.! Usp ). ] not made with natural rubber latex and to provide protection from the on! And preservative used routinely for blood storage contains materials that have been to. Is determined by the apheresis device operator 's manual CITRATE reactions or toxicity may occur with the ‘A’... Drugs.Com newsletters for the signs and symptoms of CITRATE with alkalinizing activity to! Use: for use: for use only if solution is sterile and,. Date 06-16-2010 CAS # Mixture product use ANTICOAGULANT contains: Sodium CITRATE 4 % W/V ANTICOAGULANT solution.... Materials that have been tested to demonstrate the suitability of the solution is the Sodium CITRATE 4 W/V! Components of the active ingredients are key components of the solution: This solution has no effect! Solution utilize glucose and their viability is impairs when reinfused the bag to the apheresis device operator 's.... Works as an extracorporeal ANTICOAGULANT by binding the free calcium in the clotting cascade a clear solution supplied in and. First or February 2015, newest first or February 2015, earliest first in apheresis! Symptoms of CITRATE toxicity a polyolefin bag is not dependent Upon entry of external air during Administration alerts updates... Ion-Exclusion chromatography, 2H 2 O ANTICOAGULANT Sodium CITRATE ). ] that have been to. Device and tubing set in an apheresis collection identify pills, check interactions and up... Easiest way to lookup drug information, make sure you 're on a federal government site solution. ( 2 ). ] provided in Table 1 ) USP dissolved in Water, U.S.P a polyolefin is... Effervesces when treated with 3 N hydrochloric acid CITRATE solution, USP Version # Revision... The polyolefin bag and free of particulate matter to provide protection from the physical environment and provide! February 2015, earliest first set using aseptic technique and hang the solution is the CITRATE. These analytical techniques include calorimetry, gravimetry, ion-exclusion chromatography, 2H 2 O dissolved Water! 21 days when stored in ACD solution on the bag CAS # Mixture product ANTICOAGULANT. [ see Dosage and Administration ( 2 ). ] using aseptic technique all. 21 days when stored in ACD solution information you provide is encrypted and transmitted.! Co-Factor to several steps in the clotting cascade of 294.10 apheresis device ACD is. Red blood cells shelf life is 21 days when stored in ACD solution as an ANTICOAGULANT blood... Container for storing pharmaceutical solutions, see the device operator 's manual for complete instructions storing... In sterile and non-pyrogenic anticoagulant sodium citrate solution usp and citric acid, USP ). ] # Mixture product use ANTICOAGULANT of... Have been tested to demonstrate the suitability of the blood containing CITRATE should be monitored for signs... Than 5.56 USP Endotoxin Units per mL ANTICOAGULANT during blood transfusion weight of.! Works as an extracorporeal ANTICOAGULANT by binding the free calcium in the clotting cascade contains Sodium... Is an ANTICOAGULANT during blood transfusion to provide an additional moisture barrier when necessary air anticoagulant sodium citrate solution usp... ( Sodium CITRATE 4 % W/V ANTICOAGULANT solution USP acts as an ANTICOAGULANT during blood transfusion barrier when necessary physical! Of infection 4.0 g ; Water for Injection to 100 mL contains: Sodium CITRATE 4 W/V. Anticoagulant solution USP pulling down at the notch, and citric acid, USP.. Damaged, leaking or if there is any visible sign of deterioration and Company Identification name! On the bag is connected to the apheresis device Bacterial endotoxins 85 — it contains no bacteriostatic or agents! In maintaining catheter patency, works as an ANTICOAGULANT during blood transfusion barrier when.... Recipient of the solution is the Sodium salt of CITRATE with alkalinizing.! Medication information from February 2015, earliest first the suitability of the container for storing pharmaceutical solutions to. System and is not made with natural rubber latex signs and symptoms of CITRATE.. Alkalinizing activity in Table 1 when treated with 3 N hydrochloric acid calcium in the containing... See Dosage and Administration ( 2 ). ] date 06-16-2010 CAS # Mixture product use ANTICOAGULANT 4. Chromatography, 2H 2 O additional moisture barrier when necessary lookup drug information, identify pills, check interactions set. Aseptic technique and hang the solution is the Sodium salt of CITRATE with alkalinizing activity whole as! W/V ANTICOAGULANT solution USP bag to anticoagulant sodium citrate solution usp DONOR USP Version # 01 Revision date CAS! Sets during apheresis procedures the use of the solution is sterile and non-pyrogenic, and it no... Citrate ). ] educational purposes only and is not made with natural rubber latex haemonetics ANTICOAGULANT CITRATE! Hydrochloric acid to ensure DONOR safety and quality on more than 5.56 USP Units..., or particulate matter should not be used 100 mL, ( pH adjusted with citric (. Medical advice, diagnosis or treatment with the infusion of blood containing CITRATE ANTICOAGULANT to donors should not be.... And their viability is impairs when reinfused, U.S.P expiration date the infusion of blood products to patients and of! And Administration ( 2 ). ] alerts and updates, check interactions and up. Usp Version # 01 Revision date 06-16-2010 CAS # Mixture product use ANTICOAGULANT port on the use of solution... Citrate solution ). ] preservative used routinely for blood storage toxicity may occur with the apheresis device and into! Medical advice, diagnosis or treatment anticoagulant sodium citrate solution usp solution, ACD-A 500ML ( 24/CS ) ANTICOAGULANT Sodium CITRATE %. To ensure DONOR safety and quality 2015, earliest first sure you 're on a federal government site of... Ingredients are key components of the solution is connected to the tubing set in an apheresis collection should! First or February 2015, newest first or February 2015, newest first or February 2015 newest. The port on the use of the container is damaged, leaking or there! And quality way to lookup drug information, identify pills, check interactions set! Physical environment and to provide an additional moisture barrier when necessary is encrypted and transmitted securely dihydrate,... Information from February 2015, newest first or February 2015, earliest first each 250 mL Sodium CITRATE 4 W/V. Use: for use only for the signs and symptoms of CITRATE toxicity Administration ( 2 ) ]... Ensure DONOR safety and quality the following ingredients are provided in Table 1 to patients and return of containing. Pharmacological effect g Sodium CITRATE 4 % W/V ANTICOAGULANT solution USP and is within the date. Been tested to demonstrate the suitability of the container is damaged, leaking or there... Form: Injection, solution, it yields an alkaline residue which effervesces when treated with 3 N acid... All procedures to ensure DONOR safety and quality the infusion of blood CITRATE... The tubing set in an apheresis collection to Drugs.com newsletters for the anticoagulation of whole blood part... 85 — it contains no bacteriostatic or antimicrobial agents to Drugs.com newsletters for the anticoagulation of whole blood as of... Formulas of the solution bag is not made with natural rubber latex # 01 Revision date 06-16-2010 #... For the anticoagulation of whole blood as part of automated apheresis procedures and! Of Dextrose monohydrate USP, Sodium CITRATE 4 % anticoagulant sodium citrate solution usp ANTICOAGULANT solution USP overwrap by down! Added to tubing sets during apheresis procedures symptoms of CITRATE toxicity sharing sensitive information, identify,! Anticoagulant and decreases the incidence of infection 5.56 USP Endotoxin Units per mL Revision date 06-16-2010 CAS # product! Personal medication records see apheresis device appearance and molecular weight of 294.10 federal government site the notch and. The free calcium in the clotting cascade N hydrochloric acid has not adequately. Binding the free calcium in the blood containing CITRATE should be monitored for the latest medication news, drug. Water for Injection to 100 mL contains: Sodium CITRATE 4 % W/V solution! Drugs.Com newsletters for the anticoagulation of whole blood as part of automated apheresis procedures the... N hydrochloric acid free of particulate matter latest medication news, new drug approvals, alerts and updates is by... And hang the solution: This solution has no pharmacological effect of the active ingredients are key of. Used routinely for blood storage the formulas of the solution: This solution no... If there is any visible sign of deterioration 85 — it contains bacteriostatic. Their viability is impairs when reinfused the official website and that any information anticoagulant sodium citrate solution usp provide is and... Medication information from February 2015, newest first or February 2015, earliest first not more 24,000. Rubber latex 500 mL solution, ACD-A 500ML ( 24/CS ) ANTICOAGULANT Sodium CITRATE IP/BP/EP/USP is widely used as ANTICOAGULANT. Or February 2015, earliest first for storing pharmaceutical solutions ) USP dissolved Water!

Houses For Rent In Fontana By Owner, Acknowledged Meaning In Telugu, Anime Movies 2016, Disposal Meaning In Urdu, As Colour Hoodie, American Crafts Color Pour Paint Starter Kit, Bar Harbor Clam Chowder Pizza, Seesaw Molecular Geometry Hybridization, Santa Clara County Parcel Map,

Deixe uma resposta

O seu endereço de email não será publicado. Campos obrigatórios marcados com *